A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809

Conditions:   Osteoarthritis;   Rheumatoid Arthritis;   Back Pain;   Acute Upper Respiratory Tract Infection Interventions:   Drug: DW1809;   Drug: DW1809-1 Sponsor:   Daewon Pharmaceutical Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials